Cilo Cybin announces results; eyes pharmaceutical acquisition

Cilo Cybin Holdings Limited (JSE:CCCE) has released its audited annual financial statements for the year ended 31 March 2025. Investment revenue soared to ZAR 4.829 million, a 354% increase from the previous year, attributed to funds raised in the company's Initial Public Offering. Cilo Cybin recorded a loss for the period of ZAR 585.7 thousand, compared to a profit of ZAR 455.4 thousand in 2024. Basic earnings per share declined to a loss of 0.85 cents per share.